Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers

The CD133 transmembrane protein is a well-recognized stem cell marker that has been used to isolate putative cancer stem cell populations from gastric cancers (GCs). However, the molecular features or biomarke...

Source: BMC Cancer - February 4, 2019 Category: Cancer & Oncology Authors: Tae-Min Kim, Yoon Ho Ko, Shin Jung Ha and Han Hong Lee Tags: Research article Source Type: research